Document reference

2017/2822(DEA)  
Biocidal products: scientific criteria for the determination of endocrine-disrupting properties  
Basic information  

2017/2822(DEA)

DEA - Delegated acts procedure

Supplementing 2009/0076(COD)

Subject
3.70.13 Dangerous substances, toxic and radioactive wastes (storage, transport)
4.60.08 Safety of products and services, product liability

Status

Procedure completed - delegated act enters into force

 

Key players  
  • Committee responsible
    Rapporteur
    Appointed
    ENVI  
    Environment, Public Health and Food Safety
    Committee for opinion
    Rapporteur for opinion
    Appointed
    IMCO  
    Internal Market and Consumer Protection
    (Associated committee)
Key events  
04/09/2017
Non-legislative basic document published
04/09/2017
Initial period for examining delegated act 2 month(s)
13/09/2017
Committee referral announced in Parliament
13/09/2017
Referral to associated committees announced in Parliament
17/10/2017
Delegated act not objected by Council
14/11/2017
Delegated act not objected by Parliament
Technical information  
Procedure reference
2017/2822(DEA)
Procedure type
DEA - Delegated acts procedure
Procedure subtype
Examination of delegated act
Stage reached in procedure
Procedure completed - delegated act enters into force
Committee dossier
ENVI/8/10938
Documentation gateway  
  • European Commission 
    Non-legislative basic document
     
    04/09/2017
    EC
     
    Document attached to the procedure
     
    C(2018)3067
    15/05/2018
    EC
     
    Document attached to the procedure
     
    C(2018)7828
    20/11/2018
    EC
     
  • All 
    Non-legislative basic document
       
    04/09/2017
    EC
     
    Document attached to the procedure
       
    C(2018)3067
    15/05/2018
    EC
     
    Document attached to the procedure
       
    C(2018)7828
    20/11/2018
    EC